Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 12 min ago
Peer-reviewedLicence not statedMédecine et Maladies Infectieuses Formation

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

Related

  1. Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment
    L. Feghoul, S. Chevret, A. Cuinet +10
    Clinical Microbiology and InfectionPeer-reviewedLicence not statedFull text69 citedEpidemiology & public healthHAL
  2. Impact of two rounds of azithromycin mass drug administration on active trachoma and ocular Chlamydia trachomatis infection in Naoero
    Carleigh S. Cowling, Sue-Chen Apadinuwe, Anasaini Cama +10
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BY 4.0Full textImmunologyEpidemiology & public healthPLOS
  3. A Transfusion-transmitted Chronic Hepatitis E Virus Infection after Allogeneic Bone Marrow Transplantation with Viral Clearance Following Immunosuppression Tapering
    Keijiro Sato, Hiroko Kazumoto, Ami Tanaka +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE
  4. Antibodies targeting phage fiber and nozzle proteins impair Acinetobacter baumannii phage therapy by blocking infection and promoting immune clearance
    Heng Xue, Xinfeng Li, Guibo Rao +7
    PLOS BiologyPeer-reviewedCC BY 4.0Full textCell biologyImmunologyPLOS
  5. Cervicovaginal lipid mediator profiles during high-risk HPV infection associated with subsequent viral clearance or persistence: an exploratory pilot study
    Matteo Mucci, Matteo Mucci, Antonio Recchiuti +4
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
BibTeX
@article{molina2026evidence,
  title = {{No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection}},
  author = {J.M. Molina and Constance Delaugerre and J. Le Goff and B. Mela-Lima and D. Ponscarme and L. Goldwirt and N. de Castro},
  journal = {Médecine et Maladies Infectieuses Formation},
  year = {2026},
  month = oct,
  doi = {10.1016/j.medmal.2020.03.006},
  url = {https://hal.science/hal-05783466v1},
}
RIS
TY  - JOUR
TI  - No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
AU  - J.M. Molina
AU  - Constance Delaugerre
AU  - J. Le Goff
AU  - B. Mela-Lima
AU  - D. Ponscarme
AU  - L. Goldwirt
AU  - N. de Castro
PY  - 2026
DA  - 2026/10/07
JO  - Médecine et Maladies Infectieuses Formation
DO  - 10.1016/j.medmal.2020.03.006
UR  - https://hal.science/hal-05783466v1
SN  - 2772-7432
SN  - 2772-7432
ER  -